Mitcef-CV Tablet
Marketer
Mits Healthcare Pvt Ltd
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Mitcef-CV Tablet
Cefixime and Clavulanate Potassium tablets are prescribed to combat diverse bacterial infections. This combination medication inhibits microbial growth, curbing infection spread. Adhere strictly to your doctor's prescribed dosage. Consumption with or without food is acceptable, but consistent timing maximizes effectiveness. Exceeding the recommended dose can be harmful. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation reduces efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your physician promptly. Seek immediate medical attention for allergic reactions (rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications before starting this treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and ample hydration facilitate recovery. Your doctor may order lab tests to monitor treatment effects.
Primary Ingredients of Mitcef-CV Tablet
There is no text provided to rephrase. Please provide the text you wish to be rewritten.
Uses of Mitcef-CV Tablet
Managing bacterial infections
Major Benefits of Mitcef-CV Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mitcef-CV Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Mitcef-CV Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Mitcef-CV Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mitcef-CV Tablets can be consumed with or without food, although consistent timing is recommended.
How Mitcef-CV Tablet works:
Cefuroxime and Clavulanic Acid, the components of Mitcef-CV Tablet, act synergistically to combat bacterial infections. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Clavulanic Acid, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefuroxime's effects. This combination broadens Cefuroxime's effectiveness and overcomes bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Mitcef-CV Tablet use alongside alcohol consumption poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefixime (Mitcef-CV) tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefixime (Mitcef-CV) tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingNOT RELEVANT
Inapplicable, given Mitcef-CV Tablet's intended use is restricted to hospitalized individuals.
KidneyCONSULT YOUR DOCTOR
Data regarding Mitcef-CV Tablet use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Mitcef-CV Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mitcef-CV Tablet :
Should you forget a Mitcef-CV Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mitcef-CV Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |



